We co-hosted an online course on COVID vaccine science for journalists. The course content was conceptualised by Bhekisisa and the Centre for Evidence-based Health Care...
New research shows that protection against the 501Y.V2 variant could also extend to other variants — including the original virus circulating the country and the variant first identified in Brazil. Understanding the immune response to the new form of the virus in South Africa can help shape how vaccines are designed for more long-lasting and wider protection.
More COVID vaccines are arriving in South Africa over the next few weeks. These jabs are allocated for healthcare workers as part of the Sisonke trial. Find out where they'll be available.
The new coronavirus has changed a lot about our lives and children haven’t been spared. Warnings about the coronavirus just before South Africa’s lockdown in...
The COVID-19 pandemic disrupted access to services for HIV prevention and treatment — but before that great progress had been made in these areas. An ever-expanding toolkit of new interventions and medications has helped turn what was once a death sentence into a manageable chronic condition. Find out more.
The first cases of Aids were recorded four decades ago this year. So many years later the fight is far from over, but there have been some huge victories nonetheless. Take a look back.
In December 2020, scientists announced that a new variant of the coronavirus had been identified in South Africa. Here's a look at what we've learnt in the past month about the new variant that is driving the country's second wave of infections.
South Africa’s government cannot handle the COVID-19 vaccine rollout alone, these activists say. That’s why it’s time for citizens to get involved in this ‘life or death’ issue.
Following the festive season, President Cyril Ramaphosa announced new measures to deal with the rising number of coronavirus infections. Find out the latest developments in South Africa’s planned response to the epidemic.
With the first COVID jabs beginning to roll out, South Africa has announced its plan to reach two-thirds of the population once doses reach our shores. The country is expecting to receive its first share of available shots within the second quarter of this year. Here’s a look at who will get it and how.
Between understanding medical terminology and decoding legal documents, reporting on negligence cases can be complicated. A media lawyer shares her expert tips for journalists.
The dark days of the HIV pandemic are over, but patients still face social stigma. And emotional distress that can push them to stop treatment or even into a deep depression. Hear it first-hand from people who’ve lived it.
Bhekisisa speaks to researchers from the SHINE TB trial on advances the study has made in shortening treatment periods for children with minimal TB.
Finally, a better HIV prevention choice for women. Here’s what we know about cabotegravir and what we don’t.
Journalists have immersed themselves in the COVID-19 story for months. But at what cost to their mental health? A recent study found that three quarters of reporters surveyed felt significant emotional distress.
Cochrane South Africa and the Medical Research Council explain how research studies are designed and which are best to use in your reporting.